CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
paracetamol +1 moredrug
Likely dose
paracetamol 1500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02237989
NCT02237989N/ACompleted
CompareCT.gov

Effects Of Native Collagen Type 2 Treatment In Knee Osteoarthritis : A Randomized Controlled Trial

Eskisehir Osmangazi University·interventional·Posted Sep 12, 2014·Updated Sep 18, 2020

In Brief

A clinical study evaluating paracetamol and paracetamol+native collagen type 2 for Knee Osteoarthritis. Completed, enrolled 39 participants.

Detailed Summary

The aim of this study was to evaluate symptomatic efficacy of native collagen type 2 on joint pain and function and its effects on urinary biological markers related to cartilage degeneration in patients with knee osteoarthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 12, 2014
Enrollment StartJan 1, 2013
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.8 years ago

Interventions

paracetamoldrug

1500 mg

paracetamol+native collagen type 2drug

paracetamol (1500 mg) + native collagen type 2 (10mg)